clinical trials

March 7, 2016March 7, 2016

Two Phase 3 Trials for Asthma Drug Lebrikizumab Have Differing Results, Genentech Reports

Asthma, News

Genentech, a member of the Roche Group, recently reported top-line data from two Phase 3 clinical trials assessing the efficacy and safety of lebrikizumab in people with uncontrolled asthma despite ... Read more

December 11, 2015December 11, 2015

Worldwide Patient Registry Launched for Primary Ciliary Dyskinesia

COPD, News

The European Lung Foundation has announced the launch of the first international patient registry for primary ciliary dyskinesia (PCD), a rare autosomal recessive disorder leading to chronic and recurring upper ... Read more

December 9, 2015December 9, 2015

PAH Cell Therapy Shows Safety, Effectiveness in Phase 1 Study

News

Pluristem Therapeutics, Inc. has received notice from United Therapeutics Corp. ending its licensing agreement to develop PLX-PAD for the treatment of pulmonary arterial hypertension (PAH). According to a press release, Pluristem, ... Read more

November 25, 2015November 25, 2015

AstraZeneca’s Treatment for Advanced NSCLC Is Approved by FDA

Lung Cancer, News

The U.S. Food and Drug Administration (FDA) has granted accelerated approval for AstraZeneca’s Tagrisso (osimertinib), an oral prescription for the treatment of patients with advanced non-small cell lung cancer (NSCLC). The drug is ... Read more

November 20, 2015November 20, 2015

Blood Test Finding Lung Cancer in Patients in Ongoing Study

Lung Cancer, News

VolitionRx Limited recently announced initial data showing a high level of accuracy and specificity in the use of its NuQ® blood tests in the detection of lung cancer. Lung cancer is characterized by ... Read more

November 17, 2015May 12, 2016

DYNAGITO COPD Clinical Trial to Test Investigational Inhaler Drug

COPD, News

Clinical Trials Research announced their participation in a new COPD clinical study to measure the performance and safety of a combination therapy inhaler that includes tiotropium and olodaterol. In COPD – ... Read more

October 29, 2015November 5, 2015

Boehringer Reports Efficacy of OFEV in Idiopathic Pulmonary Fibrosis Studies

Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim Pharmaceuticals, Inc., recently presented post-hoc analyses from the Phase III INPULSIS™ clinical trials at the American College of Chest Physicians Annual Meeting (CHEST 2015) in Montreal, Canada. Results ... Read more